当前位置:产品>信号通路产品>抑制剂>产品详情

Pimecrolimus
Catalog Number: E1KS5004
Amount: 10mg1​ PHYSICAL AND CHEMICAL PROPERTIES
Applications: Reactivity:
产品类型: Unconjugated
发货周期: 现货
说明书:     PDF
总价格:    151.2元
选择数量:

-
+

咨询客服
概述
  • Catalog Number:

    E1KS5004
  • Amount:

    10mg1​ PHYSICAL AND CHEMICAL PROPERTIES

2​ Biological Activity
Pimecrolimus caused a strong and dose-dependent inhibition of anti-IgE–induced release of histamine from mast cells and basophils (maximally 73% and 82%, respectively, at 500 nmol/L pimecrolimus) and of mast cell tryptase (maximally 75%) and a less pronounced inhibition of LTC4 (maximally 32%) and of calcium ionophore plus phorbol myristate acetate–induced mast cell TNF-α release (90% maximum at 100 nmol/L pimecrolimus). [1]
In the pig model, topical SDZ ASM 981 was as effective as the ultrapotent corticosteroid clobetasol-17-propionate, and when compared with a series of commercial topical corticosteroid preparations, 0.1% SDZ ASM 981 had equivalent efficacy to clobetasol-17-propionate (0.05%), the most potent product on the market. Unlike the corticosteroid, however, SDZ ASM 981 did not cause skin atrophy in pigs. [2]
SDZ ASM 981 inhibits the proliferation of human T cells after antigen-specific or non-specific stimulation. It downregulates the production of Th1 [interleukin (IL)-2, interferon-γ] and Th2 (IL-4, IL-10) type cytokines after antigen-specific stimulation of a human T-helper cell clone isolated from the skin of an atopic dermatitis patient. SDZ ASM 981 inhibits the phorbol myristate acetate/phytohaemagglutinin-stimulated transcription of a reporter gene coupled to the human IL-2 promoter in the human T-cell line Jurkat and the IgE/antigen-mediated transcription of a reporter gene coupled to the human tumour necrosis factor (TNF)-α promoter in the murine mast-cell line CPII. [3]
3​ References:
[1] Torsten Zuberbier et al. Journal of Allergy and Clinical Immunology. 2001 August;108(2):275-280
[2] Meingassner J. G. et al. British Journal of Dermatology.1997, 137(4):568 – 576
[3] Grassberger M et al. Br J Dermatol. 1999 Aug; 141(2):264-73
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.

2​ Biological Activity Pimecrolimus caused a strong and dose-dependent inhibition of anti-IgE–induced release of histamine from mast cells and basophils (maximally 73% and 82%, respectively, at 500 nmol/L pimecrolimus) and of mast cell tryptase (maximally 75%) and a less pronounced inhibition of LTC4 (maximally 32%) and of calcium ionophore plus phorbol myristate acetate–induced mast cell TNF-α release (90% maximum at 100 nmol/L pimecrolimus). [1] In the pig model, topical SDZ ASM 981 was as effective as the ultrapotent corticosteroid clobetasol-17-propionate, and when compared with a series of commercial topical corticosteroid preparations, 0.1% SDZ ASM 981 had equivalent efficacy to clobetasol-17-propionate (0.05%), the most potent product on the market. Unlike the corticosteroid, however, SDZ ASM 981 did not cause skin atrophy in pigs. [2] SDZ ASM 981 inhibits the proliferation of human T cells after antigen-specific or non-specific stimulation. It downregulates the production of Th1 [interleukin (IL)-2, interferon-γ] and Th2 (IL-4, IL-10) type cytokines after antigen-specific stimulation of a human T-helper cell clone isolated from the skin of an atopic dermatitis patient. SDZ ASM 981 inhibits the phorbol myristate acetate/phytohaemagglutinin-stimulated transcription of a reporter gene coupled to the human IL-2 promoter in the human T-cell line Jurkat and the IgE/antigen-mediated transcription of a reporter gene coupled to the human tumour necrosis factor (TNF)-α promoter in the murine mast-cell line CPII. [3] 3​ References: [1] Torsten Zuberbier et al. Journal of Allergy and Clinical Immunology. 2001 August;108(2):275-280 [2] Meingassner J. G. et al. British Journal of Dermatology.1997, 137(4):568 – 576 [3] Grassberger M et al. Br J Dermatol. 1999 Aug; 141(2):264-73 The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.

相关推荐

Responsive image
PD98059   
Catalog Number:E1KS1177
Amount:10mg
Reactivity:
Applications:    
Swiss-Prot No.
Price:151.2元
Responsive image
Catalog Number:E1KS2297
Amount:50mg
Reactivity:
Applications:    
Swiss-Prot No.
Price:151.2元
Responsive image
Catalog Number:E1KS1230
Amount:5mg
Reactivity:
Applications:    
Swiss-Prot No.
Price:151.2元